Skip to content
MMyGLP Reviews

Midi Health Tirzepatide Review 2026

Compounded GLP-1/GIP from the same insurance-backed, membership-free structure — with a $34-a-week microdose route alongside.

Updated 2026-09-18 · 3 min read · Prices verified from Midi Health's own site

Editorial still life representing Midi Health's compounded Tirzepatide offering

The verdict

Midi lists its compounded GLP-1/GIP alongside its GLP-1 at the same published floor of $164 per four-week supply, which is unusual — tirzepatide normally carries a $50 to $100 premium. If that floor genuinely applies to the dual agonist, Midi is among the better-value tirzepatide routes here, before counting the insurance position. It also offers microdosing from $34 a week for eligible patients, which needs the same scrutiny as every microdose tier.

Advertised price
From $164 per 4 weeks
What you actually pay
From $164 + per-visit fees
Transparency4/5
Value4/5
Clinical depth5/5

Best for

Midlife women wanting tirzepatide with clinicians who understand the hormonal context and visits billed to insurance.

Skip it if

You want a single flat monthly figure with no per-visit charges.

Midi publishes one floor price covering both its compounded GLP-1 and its GLP-1/GIP, which is worth pressing on, because almost nobody else prices the two molecules the same.

The published line is compounded GLP-1 and GLP-1/GIP starting at $164 per four-week supply, varying by medication, format and dose, with shipping and supplies included. Across the rest of the market, compounded tirzepatide costs meaningfully more than semaglutide — CoreAge Rx charges $79 on a 12-month plan and $129 on a 12-month plan, Eden $99 and $199, Measured $119 and $219.

So either Midi's dual agonist is unusually cheap, or the $164 floor applies mainly to semaglutide and tirzepatide sits higher within the stated range. The page does not resolve it, which makes this the first question to ask.

The microdose route

Midi advertises microdosing from $34 a week for eligible patients, prescribed where clinically appropriate — roughly $147 over four weeks, its cheapest published route into treatment.

Where a dose sits on the studied ladder

Move the slider to see whether a dose is one the weight-loss trials actually used. Doses below the studied range may still suit you — they simply have no trial result attached.

MicrodoseTrial maintenance

Standard titration step

Standard schedule: Weeks 1–4

The standard starting dose. Intended to build tolerance, not to produce weight loss.

In the trial programme behind Wegovy, adults reached a 2.4 mg weekly maintenance dose and lost an average of about 15% of body weight over 68 weeks.

Titration schedules are the standard ones for the approved products and are shown for orientation, not as a dosing instruction. Compounded products are not FDA-approved and your prescriber sets your schedule. Never change a dose on the basis of a web page.

What the visit structure buys

Fifteen-minute follow-ups exist specifically to adjust dose over time, which matches tirzepatide's stepwise titration well. A clinician reviewing you at each step is a better fit for this molecule than a chat inbox, and it is covered where Midi is in-network.

Self-pay, those same follow-ups are $150 each, so the cadence that makes the clinical model good also makes the cash model expensive. Price both before choosing.

What it actually costs per year

Advertised prices in this category are usually medication only. Add the membership back in and the ranking changes. Pick a provider, or enter the quote you were given.

One-month semaglutide rate. Starting at $79/month equivalent requires a 12-month plan ($948 total); confirm payment and renewal terms.

$
$
1 month24 months
First month
$139
Every month after
$139
Total over 12 months
$1,668

No membership on this plan, so every dollar goes to medication and care.

Figures are the providers' own published prices as of our last review of each. Promotional rates, multi-month prepayment and dose changes can all move these numbers — confirm at checkout.

What compounded tirzepatide actually is

Tirzepatide is the active ingredient in Mounjaro and Zepbound, both FDA-approved products from Eli Lilly. Unlike semaglutide, it acts on two receptors — GLP-1 and GIP — which is the basis for the larger average weight reductions seen in its trials. A compounded version is prepared by a pharmacy and is not FDA-approved or FDA-evaluated.

Compounded tirzepatide is consistently more expensive than compounded semaglutide, typically by $50 to $100 a month. That gap is real and reflects the raw material, so a provider pricing them identically is worth a question rather than a celebration.

Dosing usually starts at 2.5 mg weekly and escalates in 2.5 mg steps. As with semaglutide, dose-flat pricing is worth substantially more than a low starting price, because the starting dose is not the dose most people end up on.

Side effects mirror semaglutide's — predominantly gastrointestinal, worst after dose increases — though some patients report tirzepatide is better tolerated at equivalent efficacy. That is an individual matter and not something a telehealth intake form can predict for you.

Before you buy from anyone

  1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
  2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
  3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
  4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
  5. Ask whether a refund is available if a provider declines to prescribe.
  6. Tell the prescriber every medication and supplement you take, including anything bought online.

Frequently asked questions

How much is Midi's compounded tirzepatide?
Midi publishes a floor of $164 per four-week supply covering both its compounded GLP-1 and GLP-1/GIP, varying by medication, format and dose. Since tirzepatide normally costs more than semaglutide, confirm the figure for the dual agonist specifically.
Does Midi offer microdosing?
Yes, from $34 a week for eligible patients where clinically appropriate. Lower-dose regimens are not the doses studied in the registrational trials.
Are follow-up visits included?
No — Midi charges per visit. Follow-ups are 15 minutes, covered where Midi is in-network with your plan or $150 each self-pay.

Same provider, other medication

Midi Health Semaglutide ReviewIn-network in all 50 states with no membership fee, from clinicians trained in midlife women's health — you pay per visit instead.

Other tirzepatide providers

How we make money. CoreAge Rx is a paid partner and we earn a commission when you use these links. That pays for this site. It does not change what we publish — every figure on this page comes from CoreAge Rx's own site and is dated, and the ranking criteria are published above the list.

Medical disclaimer

This review is editorial research about a commercial service. It is not medical advice, and it is not a recommendation to start, stop or change any treatment. GLP-1 medications are prescription drugs with real contraindications and side effects. Decisions about whether they are appropriate for you belong with a qualified clinician who knows your medical history. Prices and terms in this category change frequently — we publish the date each review was verified and link every source, but you should confirm current details with the provider before purchasing.